Frequency of injuries associated with syncope in the prevention of syncope trials
Open Access
- 20 September 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 22 (12), 1896-1903
- https://doi.org/10.1093/europace/euaa246
Abstract
Syncope can lead to injuries. We determined the frequency, severity, and predictors of injuries due to syncope in cohorts of syncope patients. Participants were enrolled in the POST2 (fludrocortisone) and POST4 (midodrine) vasovagal syncope (VVS) randomized trials, and POST3 enrolled patients with bifascicular block and syncope. Injury was defined as minor (bruising, abrasions), moderate (lacerations), and severe (fractures, burns, joint pain), and recorded up to 1 year after enrolment. A total of 459 patients (median 39 years) were analysed. There were 710 faints occurred in 186 patients during a 1-year follow-up. Fully 56/186 (30%) of patients were injured with syncope (12% of overall group). There were 102 injuries associated with the 710 faints (14%), of which 19% were moderate or severe injuries. Neither patient age, sex, nor the presence of prodromal symptoms associated with injury-free survival. Patients with bifascicular block were more prone to injury (relative risk 1.98, P = 0.018). Patients with ≥4 faints in the prior year had more injuries than those with fewer faints (relative risk 2.97, P < 0.0001), but this was due to more frequent syncope, and not more injuries per faint. In VVS patients, pharmacological therapy significantly reduced the likelihood of an injury due to a syncopal spell (relative risk 0.64, P = 0.015). Injury severity did not associate with age, sex, or prior-year syncope frequency. Injuries are frequent in syncope patients, but only 4% of injuries were severe. None of age, sex, and prodromal symptoms associate with injury.Funding Information
- Cardiac Arrhythmia Network of Canada
- Networks of Centres of Excellence
- Canadian Institutes of Health Research
This publication has 18 references indexed in Scilit:
- Fludrocortisone for the Prevention of Vasovagal SyncopeJournal of the American College of Cardiology, 2016
- What factors influence parents’ perception of the quality of life of children and adolescents with neurocardiogenic syncope?Health and Quality of Life Outcomes, 2016
- Comparison of Incidence, Predictors, and the Impact of Co-Morbidity and Polypharmacy on the Risk of Recurrent Syncope in Patients <85 Versus ≥85 Years of AgeThe American Journal of Cardiology, 2013
- Rationale for the prevention of syncope trial IV: assessment of midodrineClinical Autonomic Research, 2012
- Empiric pacemaker compared with a monitoring strategy in patients with syncope and bifascicular conduction block--rationale and design of the Syncope: Pacing or Recording in ThE Later Years (SPRITELY) studyEP Europace, 2012
- A standardized education protocol significantly reduces traumatic injuries and syncope recurrence: an observational study in 316 patients with vasovagal syncopeEP Europace, 2011
- Physical injuries caused by a transient loss of consciousness: main clinical characteristics of patients and diagnostic contribution of carotid sinus massageEuropean Heart Journal, 2007
- Prevention of Syncope Trial (POST)Circulation, 2006
- Short-term evolution of vasovagal syncope: Influence on the quality of lifeInternational Journal of Cardiology, 2005
- Prospective evaluation and outcome of patients admitted for syncope over a 1 year periodEuropean Heart Journal, 2002